{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:01:10Z","timestamp":1761930070657},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective was to examine whether attendance in the mass cervical screening programme has implications for the prognosis when cervical cancer is diagnosed. We performed a retrospective analysis of all cases of cervical cancer between 1st of January 2012 and 31st of December 2014 in the Region of Southern Denmark. The cases were retrieved from the\u00a0Danish National Pathology Registry, PatoBank. Odds ratios (OR) with confidence intervals (95% CI) were calculated for attendees versus non-attendees of the screening programme by using \u03c72-test. 216 patients were included in the study. 61.6% of the study population had not attended the screening programme. Patients who had attended the programme were characterised by disease in low stage (OR\u2009=\u20093.14, 95% CI; 1.66 to 5.92), treatment with surgery alone (OR\u2009=\u20092.63, 95% CI; 1.49 to 4.64) and a lower risk of death (OR\u2009=\u20090.36, 95% CI; 0.15 to 0.87). Adenocarcinomas were more often detected among attendees of the programme compared to squamous cell carcinomas (OR\u2009=\u20094.06, 95% CI; 2.03 to 8.14). Statistically significant results regarding relapse of cancer (OR\u2009=\u20090.62, 95% CI; 0.23 to 1.68, p\u2009=\u20090.47) and lymph node metastases (OR\u2009=\u20090.62, 95% CI; 0.32 to 1.21, p\u2009=\u20090.19) were not found. Cervical cancer detected in women who had attended the mass cervical screening programme prior to the diagnosis, was shown to have a statistically significant lower FIGO stage (p\u2009=\u20090.0004) and was therefore linked to less extensive treatment options. Continued focus on increasing the participation rate of the programme is of importance, as the nonattendance rate continues to be high.<\/jats:p>","DOI":"10.1038\/s41598-019-56833-w","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T11:02:45Z","timestamp":1577790165000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Screening history and FIGO-stages among Danish women with cervical cancer in 2012\u20132014: a register-based study"],"prefix":"10.1038","volume":"9","author":[{"given":"Abir Khalil","family":"Bchtawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinem","family":"Saritas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doris","family":"Schledermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 dePont","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten Marie","family":"Jochumsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"56833_CR1","unstructured":"NORDCAN. Kr\u00e6ftstatistik: N\u00f8gletal og figurer Danmark\u2013Livmoderhals. 2017. Available from, https:\/\/www.cancer.dk\/dyn\/resources\/File\/file\/6\/3716\/1400664054\/nordcan-statistik-sygdomme-livmoderhals.pdf [cited March, 2019]."},{"key":"56833_CR2","unstructured":"Sundhedsstyrelsen. Screening for livmoderhalskr\u00e6ft - Anbefalinger [Screening for cervical cancer - Recommendations]. The Danish National Board of Health, 2012. Available from, http:\/\/www.sst.dk\/publ\/Publ2012\/SYB\/Kraeft\/ScreenLivmoderhalskrftAnbef.pdf [cited June 7, 2016]."},{"key":"56833_CR3","unstructured":"Sundhedsdatastyrelsen. Nye kr\u00e6fttilf\u00e6lde i Danmark - Cancerregisteret [New cases of cancer in Denmark - The Danish Cancerregistry]. Sundhedsdatastyrelsen, 2014. Available from, http:\/\/sundhedsdatastyrelsen.dk\/-\/media\/sds\/filer\/find-tal-og-analyser\/sygdomme\/cancerregisteret\/cancerregisteret-2014.pdf?la=da [cited June 7, 2016]."},{"key":"56833_CR4","unstructured":"DKLS. Dansk Kvalitetsdatabase for Livmoderhalskr\u00e6ftscreening - \u00c5rsrapport 2016 [Danish Cervical Cancer Screening Quality Assurance Database - Annual Report, 2016] 2016. Available from, https:\/\/www.sundhed.dk\/content\/cms\/82\/4682_dkls_%C3%A5rsrapport2016_offentligversion.pdf [cited March, 2019]."},{"issue":"3","key":"56833_CR5","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/0284186X.2017.1355110","volume":"57","author":"E Lynge","year":"2018","unstructured":"Lynge, E. et al. Cervical screening in Denmark \u2013 a success followed by stagnation. Acta Oncologica. 57(3), 354\u201361. (2018).","journal-title":"Acta Oncologica."},{"issue":"2","key":"56833_CR6","doi-asserted-by":"publisher","first-page":"e000847","DOI":"10.1136\/bmjopen-2012-000847","volume":"2","author":"D Fontaine","year":"2012","unstructured":"Fontaine, D., Narine, N. & Naugler, C. Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis. BMJ open. 2(2), e000847 (2012).","journal-title":"BMJ open."},{"issue":"9","key":"56833_CR7","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/bjc.2015.339","volume":"113","author":"M Rebolj","year":"2015","unstructured":"Rebolj, M. et al. Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark. British journal of cancer. 113(9), 1259\u201374 (2015).","journal-title":"British journal of cancer."},{"key":"56833_CR8","unstructured":"Sundhedsstyrelsen. Screening for livmoderhalskr\u00e6ft - Anbefalinger [Screening for cervical cancer - Recommendations]. The Danish National Board of Health, 2007. Available from, http:\/\/www.sst.dk\/~\/media\/2C40A729A6D8452984626577FFD2C752.ashx [cited June 7, 2016]."},{"key":"56833_CR9","unstructured":"Danmarks Statistik. Folketal [Population in Denmark]: Stastics Denmark; 2016. Available from, https:\/\/www.dst.dk\/da\/Statistik\/emner\/befolkning-og-befolkningsfremskrivning\/folketal [cited June 7, 2016]"},{"key":"56833_CR10","unstructured":"DKLS. Dansk Kvalitetsdatabase for Livmoderhalskr\u00e6ftscreening - \u00c5rsrapport 2015 [Danish Cervical Cancer Screening Quality Assurance Database - Annual Report, 2015]. 2016. Available from, https:\/\/www.sundhed.dk\/content\/cms\/82\/4682_dkls-%C3%A5rsrapport-2015.pdf [cited January, 2018]."},{"key":"56833_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"P Sergio","year":"2009","unstructured":"Sergio, P. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. International Journal of Gynecolgy and Obstetrics. 105, 103\u20134 (2009).","journal-title":"International Journal of Gynecolgy and Obstetrics."},{"issue":"9","key":"56833_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/jnci\/djn099","volume":"100","author":"B Andrae","year":"2008","unstructured":"Andrae, B. et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. Journal of the National Cancer Institute. 100(9), 622\u20139 (2008).","journal-title":"Journal of the National Cancer Institute."},{"issue":"2","key":"56833_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/eurpub\/ckm043","volume":"18","author":"J Spayne","year":"2008","unstructured":"Spayne, J. et al. Invasive cervical cancer: a failure of screening. European journal of public health. 18(2), 162\u20135 (2008).","journal-title":"European journal of public health."},{"issue":"2","key":"56833_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canep.2013.12.007","volume":"38","author":"JH Kristensson","year":"2014","unstructured":"Kristensson, J. H., Sander, B. B., von Euler-Chelpin, M. & Lynge, E. Predictors of non-participation in cervical screening in Denmark. Cancer epidemiology. 38(2), 174\u201380 (2014).","journal-title":"Cancer epidemiology."},{"issue":"11","key":"56833_CR15","doi-asserted-by":"publisher","first-page":"e012753","DOI":"10.1136\/bmjopen-2016-012753","volume":"6","author":"T Akinyemiju","year":"2016","unstructured":"Akinyemiju, T., Ogunsina, K., Sakhuja, S., Ogbhodo, V. & Braithwaite, D. Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO's Study on Global Ageing and Adult Health (SAGE). BMJ open. 6(11), e012753 (2016).","journal-title":"BMJ open."},{"issue":"5","key":"56833_CR16","first-page":"835","volume":"21","author":"E Ibfelt","year":"2012","unstructured":"Ibfelt, E. et al. Socioeconomic position and stage of cervical cancer in Danish women diagnosed 2005 to 2009. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology. 21(5), 835\u201342 (2012).","journal-title":"Oncology."},{"issue":"2\u20133","key":"56833_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ypmed.2007.06.007","volume":"45","author":"AR Spence","year":"2007","unstructured":"Spence, A. R., Goggin, P. & Franco, E. L. Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Preventive medicine. 45(2\u20133), 93\u2013106 (2007).","journal-title":"Preventive medicine."},{"issue":"7","key":"56833_CR18","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/sj.bjc.6604293","volume":"98","author":"O Ingemann-Hansen","year":"2008","unstructured":"Ingemann-Hansen, O. et al. Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark. British journal of cancer. 98(7), 1292\u20134 (2008).","journal-title":"British journal of cancer."},{"issue":"1","key":"56833_CR19","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2010.09.021","volume":"120","author":"B Kirschner","year":"2011","unstructured":"Kirschner, B., Poll, S., Rygaard, C., Wahlin, A. & Junge, J. Screening history in women with cervical cancer in a Danish population-based screening program. Gynecologic oncology. 120(1), 68\u201372 (2011).","journal-title":"Gynecologic oncology."},{"key":"56833_CR20","doi-asserted-by":"publisher","first-page":"c1040","DOI":"10.1136\/bmj.c1040","volume":"340","author":"M Gok","year":"2010","unstructured":"Gok, M. et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ (Clinical research ed). 340, c1040 (2010).","journal-title":"BMJ (Clinical research ed)."},{"issue":"9","key":"56833_CR21","first-page":"1960","volume":"20","author":"A Virtanen","year":"2011","unstructured":"Virtanen, A., Nieminen, P., Luostarinen, T. & Anttila, A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology. 20(9), 1960\u20139 (2011).","journal-title":"Oncology."},{"issue":"4","key":"56833_CR22","doi-asserted-by":"publisher","first-page":"e0151978","DOI":"10.1371\/journal.pone.0151978","volume":"11","author":"E Enerly","year":"2016","unstructured":"Enerly, E. et al. Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme. PloS one. 11(4), e0151978 (2016).","journal-title":"PloS one."},{"key":"56833_CR23","unstructured":"Sundhedsstyrelsen. Screening for livmoderhalskr\u00e6ft - Anbefalinger [Screening for cervical cancer - Recommendations]. 2018. Available from, https:\/\/www.sst.dk\/da\/sygdom-og-behandling\/screening\/~\/media\/5466AB0B06184ED0969BC31DA397610D.ashx [cited March 2019]."},{"key":"56833_CR24","unstructured":"Statens Serum Institut. Questions and Answers on HPV Vaccination. Epi-News: Statens Serum Institut - National Surveillance of Communicable Diseases, 2007. Available from, http:\/\/www.ssi.dk\/~\/media\/Indhold\/EN%20-%20engelsk\/EPI-NEWS\/2007\/PDF\/EPI-NEWS%20-%202007%20-%20No%2034.ashx [cited June 7, 2016]."},{"key":"56833_CR25","unstructured":"Statens Serum Institut. HPV Vaccine in the Childhood Vaccination Programme. Epi-News: Statens Serum Institut - National Surveillance of Communicable Diseases, 2008. Available from, http:\/\/www.ssi.dk\/~\/media\/Indhold\/EN%20-%20engelsk\/EPI-NEWS\/2008\/pdf\/EPI-NEWS%20-%202008%20-%20No%2035.ashx [cited June 7, 2016]."},{"key":"56833_CR26","unstructured":"Sundhedsdatastyrelsen. Stop HPV - stop livmoderhalskr\u00e6ft [Stop HPV - Stop cervical cancer]: The Danish National Board of Health, The Danish Cancer Registries and The Danish Medical Association, 2018. Available from. http:\/\/www.stophpv.dk\/drenge-og-hpv-vaccination [cited June 12, 2018]."},{"issue":"1","key":"56833_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/1097-0142(20010225)93:1<8::AID-CNCR9001>3.0.CO;2-K","volume":"93","author":"JF Krane","year":"2001","unstructured":"Krane, J. F., Granter, S. R., Trask, C. E., Hogan, C. L. & Lee, K. R. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer. 93(1), 8\u201315 (2001).","journal-title":"Cancer."},{"issue":"9","key":"56833_CR28","first-page":"2191","volume":"14","author":"F Bray","year":"2005","unstructured":"Bray, F. et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology. 14(9), 2191\u20139 (2005).","journal-title":"Oncology."},{"issue":"9","key":"56833_CR29","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/sj.bjc.6601754","volume":"90","author":"M Zappa","year":"2004","unstructured":"Zappa, M. et al. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. British journal of cancer. 90(9), 1784\u20136 (2004).","journal-title":"British journal of cancer."},{"issue":"8","key":"56833_CR30","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s10552-015-0603-7","volume":"26","author":"B Baldur-Felskov","year":"2015","unstructured":"Baldur-Felskov, B. et al. Trends in the incidence of cervical cancer and severe precancerous lesions in Denmark, 1997\u20132012. Cancer causes & control: CCC. 26(8), 1105\u201316 (2015).","journal-title":"Cancer causes & control: CCC."},{"key":"56833_CR31","doi-asserted-by":"crossref","unstructured":"Castanon, A., Landy, R., Sasieni, P. D. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix? Int J Cancer. 2016.","DOI":"10.1002\/ijc.30152"},{"key":"56833_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-553","volume":"13","author":"JM Pimenta","year":"2013","unstructured":"Pimenta, J. M., Galindo, C., Jenkins, D. & Taylor, S. M. Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination. BMC cancer. 13, 553 (2013).","journal-title":"BMC cancer."},{"issue":"23","key":"56833_CR33","first-page":"V12140697","volume":"177","author":"A Hammer","year":"2015","unstructured":"Hammer, A., Fuglsang, K., Hogsbjerg, K. & Blaakaer, J. [Screening for cervical cancer in women older than 65 years will probably reduce the incidence and mortality]. Ugeskrift for laeger. 177(23), V12140697 (2015).","journal-title":"Ugeskrift for laeger."},{"key":"56833_CR34","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ejca.2016.12.021","volume":"74","author":"E Lynge","year":"2017","unstructured":"Lynge, E., Lonnberg, S. & Tornberg, S. Cervical cancer incidence in elderly women-biology or screening history? European journal of cancer (Oxford, England: 1990). 74, 82\u20138 (2017).","journal-title":"European journal of cancer (Oxford, England: 1990)."},{"key":"56833_CR35","unstructured":"NHS cervical screening (CSP) programme. NHSCSP audit of invasive cervical cancer: National Report 2009-2013. NHS cervical screening (CSP) programme, 2014. Available from, http:\/\/www.wolfson.qmul.ac.uk\/images\/pdfs\/nhscsp-audit-invasive-cervical-cancer-Feb_2014.pdf [cited June 7, 2016]."},{"key":"56833_CR36","unstructured":"NHS Cancer Screening Programmes. Audit of Invasive Cervical Cancers. NHS Cancer Screening Programmes, 2006. Available from, https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/437902\/nhscsp28.pdf [cited June 7, 2016]."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56833-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56833-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56833-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T18:19:40Z","timestamp":1671301180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-56833-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["56833"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-56833-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20390"}}